Matching trials
1,648 results
- 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of 0822GCC: Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- 1% Chloroprocaine(PF) vs. Bupivacaine Spinals: Complete Statistical AnalysisIndependent statistical analysis of 1% Chloroprocaine(PF) vs. Bupivacaine Spinals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03324984).
- 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: Complete Statistical AnalysisIndependent statistical analysis of 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 1565GCCIndependent statistical analysis of Decitabine and Talazoparib in Untreated AML and R/R AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02878785).
- 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775268).
- 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies: Complete Statistical AnalysisIndependent statistical analysis of 18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: Complete Statistical AnalysisIndependent statistical analysis of 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 2-DeoxyglucoseIndependent statistical analysis of A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 276Independent statistical analysis of A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 337Independent statistical analysis of BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- 3CIndependent statistical analysis of Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01120028).
- 3MVIndependent statistical analysis of Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: Complete Statistical AnalysisIndependent statistical analysis of 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: Complete Statistical AnalysisIndependent statistical analysis of 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00450242).
- 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension: Complete Statistical AnalysisIndependent statistical analysis of 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 68 Ga-PSMA for High Risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of 68 Ga-PSMA for High Risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04614363).
- 68Ga PSMA in Preprostatectomy Patients: Complete Statistical AnalysisIndependent statistical analysis of 68Ga PSMA in Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388346).
- 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- 6MPIndependent statistical analysis of A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY: Complete Statistical AnalysisIndependent statistical analysis of A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY: primary endpoint results,…
- A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica: Complete Statistical AnalysisIndependent statistical analysis of A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval,…
- A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB): Complete Statistical AnalysisIndependent statistical analysis of A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate: Complete Statistical AnalysisIndependent statistical analysis of A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Trial of CSL’s 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056): primary endpoint results, effect estimate…
- A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN):…
- A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration: primary endpoint results,…
- A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04134845).
- A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules: Complete Statistical AnalysisIndependent statistical analysis of A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection: Complete Statistical AnalysisIndependent statistical analysis of A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection: primary endpoint results, effect estimate with confidence…
- A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN): Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen (CD20+) Malignant Disease (GAUGUIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…